Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
NACRES:
NA.46
Conjugate:
unconjugated
Clone:
NK92.39, monoclonal
Application:
FACS, inhibition assay
Citations:
-
biological source
mouse
Quality Level
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
NK92.39, monoclonal
form
liquid
mol wt
calculated mol wt 65.63 kDa, observed mol wt ~N/A kDa
purified by
using protein G
species reactivity
human
packaging
antibody small pack of 100
technique(s)
flow cytometry: suitable, inhibition assay: suitable
isotype
IgG1κ
epitope sequence
Extracellular domain
Protein ID accession no.
UniProt accession no.
storage temp.
-10 to -25°C
Gene Information
human ... CD96(10225)
General description
T-cell surface protein tactile (UniProt: P40200; also known as Cell surface antigen CD96, T cell-activated increased late expression protein) is encoded by the CD96 gene (Gene ID: 10225) in human. CD96 is a single-pass type I, disulfide-linked, homodimeric, membrane glycoprotein protein of the poliovirus receptor (PVR, CD155)-nectin family that is synthesized with a signal peptide (aa 1-21), which is subsequently cleaved off to produce the mature form that contains an extracellular domain (aa 22-519), a transmembrane domain (aa 520-540), and a cytoplasmic domain (aa 541-585). It contains two Ig-like V-type 2 domains (aa 38-125 and 156-238) and one Ig-like C2-type domain (aa 269-375). These three Ig-like domains are separated from the transmembrane domain by a long region that is rich in proline, serine, and threonine. The cytoplasmic region contains a proline-rich tandem that is flanked by arginine and lysine residues and represents binding site for SH3 domain containing signaling components. CD96 is expressed mainly by cells of hematopoietic origin, in particular on T and NK cells. It is involved in adhesive interactions of activated T and NK cells during the late phase of the immune response. It promotes NK cell-target adhesion by interacting with CD155 (PVR) present on target cells. (Ref.: Aguilera, AR., et al. (2018). OncoImmunology 7(5); e1424677; Georgiev, H., et al. (2018). Front. Immunol. 9; 1072; Meyer, D., et al. (2009). J. Biol. Chem. 284(4); 2235-2244).
Immunogen
NK92 cells.
Application
Quality Control Testing
Evaluated by Flow Cytometry in Jurkat cells.
Flow Cytometry Analysis: 1.0 µg from a representative lot detected CD96 in one million Jurkat cells.
Tested Applications
Flow Cytometry Analysis: 1.0 µg from a representative lot detected CD96 in one million NK-92 cells.
Flow Cytometry Analysis: A representative lot detected CD96 in Flow Cytometry application (Fuchs, A., et al. (2004). J Immunol. 172(7):3994-8).
Inhibition: A representative lot of this antibody inhibits the binding of poliovirus receptor (PVR) ectodomain and distal Ig domains to CD96 in P815 murine mastocytoma cells. (Fuchs, A., et al. (2004). J Immunol. 172(7):3994-8).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Evaluated by Flow Cytometry in Jurkat cells.
Flow Cytometry Analysis: 1.0 µg from a representative lot detected CD96 in one million Jurkat cells.
Tested Applications
Flow Cytometry Analysis: 1.0 µg from a representative lot detected CD96 in one million NK-92 cells.
Flow Cytometry Analysis: A representative lot detected CD96 in Flow Cytometry application (Fuchs, A., et al. (2004). J Immunol. 172(7):3994-8).
Inhibition: A representative lot of this antibody inhibits the binding of poliovirus receptor (PVR) ectodomain and distal Ig domains to CD96 in P815 murine mastocytoma cells. (Fuchs, A., et al. (2004). J Immunol. 172(7):3994-8).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Biochem/physiol Actions
Clone NK92.39 is a mouse monoclonal antibody that detects CD96. It targets an epitope within the extracellular domain.
Physical form
Purified mouse monoclonal antibody IgG1 in PBS without preservatives.
Preparation Note
0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.